Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...
Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in ...
The Independent on MSN4d
‘Game changer’ immunotherapy drug could lead to increased survival rates for bladder cancer patientsThe study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...
Adding durvalumab and bevacizumab to transarterial chemoembolization improved responses and progression-free survival.
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...
They hope it will be approved by the Medicines and Healthcare Products Regulatory Agency to become the new standard of care.
A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the ...
The NRG-HN004 trial showed that durvalumab did not improve outcomes vs cetuximab in locoregionally advanced head and neck ...
There is a simple discount patient access scheme for durvalumab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...
A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback